
Sign up to save your podcasts
Or


On The Scalpel’s Edge, Dr. Tim Sayed takes a clear-eyed look at where GLP-1 weight loss medications are headed and why the landscape feels so unsettled right now.
From the FDA’s latest move against compounded GLP-1 drugs to the rise of direct-to-consumer platforms and the new TrumpRX pricing model, this is an honest, surgeon-level reflection on access, affordability, and control. Dr. Sayed shares how these shifts affect real patients, real practices, and the expectations around weight loss, plastic surgery, and long-term health.
It’s a grounded conversation about what’s changing, what may disappear, and what still matters when medicine, regulation, and patient care collide.
Contact Dr. Tim Sayed:
Phone: (858) 247-2933
Email: [email protected]
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD
By Dr. Tim SayedOn The Scalpel’s Edge, Dr. Tim Sayed takes a clear-eyed look at where GLP-1 weight loss medications are headed and why the landscape feels so unsettled right now.
From the FDA’s latest move against compounded GLP-1 drugs to the rise of direct-to-consumer platforms and the new TrumpRX pricing model, this is an honest, surgeon-level reflection on access, affordability, and control. Dr. Sayed shares how these shifts affect real patients, real practices, and the expectations around weight loss, plastic surgery, and long-term health.
It’s a grounded conversation about what’s changing, what may disappear, and what still matters when medicine, regulation, and patient care collide.
Contact Dr. Tim Sayed:
Phone: (858) 247-2933
Email: [email protected]
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD